You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

The Role of Angiopoietin-2 Across Multiple Retinal Disease States

  • Authors: Ramin Tadayoni, MD, PhD; Carl Danzig, MD; Arshad Khanani, MD
  • CME / ABIM MOC Released: 10/31/2023
  • Valid for credit through: 10/31/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Optometry - This course is COPE approved for 0.50 hours of CE credit.

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for ophthalmologists, including retinal specialists, diabetologists/endocrinologists, optometrists, and other clinicians who treat patients with neovascular age-related macular degeneration, diabetic eye disease, or retinal vein occlusion.

The goal of this activity is for learners to be better able to promptly manage retinal diseases and make informed treatment decisions based on knowledge of the latest clinical data.

Upon completion of this activity, participants will:

  • Describe the mechanism of action (MOA) of Ang-2 treatments for retinal disease
  • Consider Ang-2 clinical trial data in retinal diseases
  • Use bispecific antibody treatments


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The PIM planners and others have nothing to disclose.


Moderator

  • Ramin Tadayoni, MD, PhD

    Professor of Ophthalmology
    Université de Paris
    Head of Ophthalmology
    Lariboisière, St Louis and Rothschild
    Foundation Hospital
    Paris, France

    Disclosures

    Ramin Tadayoni, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Alcon Laboratories, Inc.; Allergan; Apellis Pharmaceuticals; Bayer; Genentech; Iveric Bio; KHB; Novartis; Oculis; Roche; Thea; Zeiss
    Speaker or member of speakers bureau for: AbbVie Inc.; Alcon Laboratories Corp.; Allergan; Apellis Pharmaceuticals; Bayer; Genentech; Iveric Bio; KHB; Novartis; Oculis; Roche; Thea; Zeiss
    Research funding from: AbbVie Inc.; Alcon Laboratories, Inc..; Allergan; Bayer; Novartis; Zeiss
    Owns stock (publicly traded) in: Oculis

Faculty

  • Carl Danzig, MD

    Affiliate Assistant Professor of Clinical Biomedical Science
    Charles E. Schmidt College of Medicine
    Florida Atlantic University
    Boca Raton, Florida, United States
    Director of Vitreo-Retinal Services
    Rand Eye Institute
    Pompano Beach, Florida, United States

    Disclosures

    Carl Danzig, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Adverum; Genentech; Iveric Bio; Kodiak Sciences; Regeneron Pharmaceuticals, Inc.; Regenxbio
    Speaker or member of speakers bureau for: Genentech; Iveric Bio
    Research funding from: Adverum; Bayer; Cognition; Curacle; Eyebio; Genentech; Gyroscope; Iveric Bio; Kodiak Sciences; Novartis; Regeneron Pharmaceuticals, Inc.; Regenxbio; Unity
    Contracted researcher for: Adverum; Bayer; Cognition; Curacle; Eyebio; Genentech; Gyroscope; Iveric Bio; Kodiak Sciences; Novartis; Regeneron Pharmaceuticals, Inc.; Regenxbio; Unity

  • Arshad Khanani, MD

    Clinical Associate Professor
    University of Nevada, Reno
    School of Medicine
    Managing Partner
    Director of Clinical Research
    Director of Fellowship
    Sierra Eye Associates
    Reno, Nevada, United States

    Disclosures

    Arshad Khanani, MD, has the following relevant financial relationships:
    Consultant or advisor for: 4D Molecular Therapeutics; AbbVie Inc.; Adverum; Aerie Pharmaceuticals, Inc.; Aldebaran; Allergan; Apellis Pharmaceuticals; Applied Genetics Technologies Corporation; Arrowhead Pharmaceuticals, Inc.; Aviceda Therapeutics; Bausch & Lomb Inc.; Broadwing Bio; Clearside; Exgenesis; EyePoint; Frontera; Genentech, Inc.; Gyroscope; iLumen; Iveric Bio; Janssen; Kartos; Kato; Kodiak Sciences; Kriya; Nanoscope; Notal Vision; Novartis; Ocular Therapeutix; Oculis; OcuTerra; Olives Bio; Opthea; Oxurion; Perfuse; PolyPhotonix; Protagonist; Ray Therapeutics; RecensMedical; Regeneron Pharmaceuticals, Inc.; Regenxbio; RevOpsis; Roche; Stealth BioTherapeutics Inc.; Thea; Unity; Vanotech; Vial
    Speaker or member of speakers bureau for: Iveric Bio
    Research funding from: 4D Molecular Therapeutics; Adverum; Annexon; Apellis Pharmaceuticals; Genentech, Inc.; Gyroscope; Iveric Bio; Kodiak Sciences; Neurotech Pharmaceuticals; NGM Biopharmaceuticals; Novartis; Ocular Therapeutix; Oculis; OcuTerra; Opthea; Oxurion; Regenxbio; Roche; Unity

Editors

  • Pakinam Aboulsaoud, PharmD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between the Postgraduate Institute for Medicine and Medscape.

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

  • For Optometrists

    Postgraduate Institute for Medicine

    Interprofessional Continuing Education

    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Medscape, LLC. Postgraduate Institute for Medicine (PIM) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

    Credit Statement: This course is COPE approved for 0.50 hour(s) of CE credit. Activity #127206 and Course ID 88057-PH. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

    Contact this provider: www.pimed.com

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Request for Credit

In order to obtain your COPE certificate, please follow the steps below at the conclusion of the activity:

  • Go to www.cmeuniversity.com
  • Login or Create a New Account (will take less than 1 minute)
    • If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    • After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  • Type in 18210 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  • Click on the activity title when it appears
  • Choose the type of credit you desire
  • Complete the online assessment
  • Receive an immediate CME/CE Certificate to download and/or print for your files

If you have questions regarding the certification of this activity, please contact PIM via email at [email protected]..

Please provide your evaluation at your earliest convenience so I can get this set up on my end.

CME / ABIM MOC

The Role of Angiopoietin-2 Across Multiple Retinal Disease States

Authors: Ramin Tadayoni, MD, PhD; Carl Danzig, MD; Arshad Khanani, MDFaculty and Disclosures

CME / ABIM MOC Released: 10/31/2023

Valid for credit through: 10/31/2024, 11:59 PM EST

processing....

Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print